Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-21-005633
Filing Date
2021-11-15
Accepted
2021-11-15 12:09:47
Documents
63
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cannarx_i10q-093021.htm   iXBRL 10-Q 1169245
2 CERTIFICATION cannarx_ex3101.htm EX-31.1 12024
3 CERTIFICATION cannarx_ex3102.htm EX-31.2 11714
4 CERTIFICATION cannarx_ex3200.htm EX-32 4945
  Complete submission text file 0001683168-21-005633.txt   4693078

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE cpmd-20210930.xsd EX-101.SCH 42020
6 XBRL CALCULATION FILE cpmd-20210930_cal.xml EX-101.CAL 54259
7 XBRL DEFINITION FILE cpmd-20210930_def.xml EX-101.DEF 158509
8 XBRL LABEL FILE cpmd-20210930_lab.xml EX-101.LAB 282642
9 XBRL PRESENTATION FILE cpmd-20210930_pre.xml EX-101.PRE 243474
10 EXTRACTED XBRL INSTANCE DOCUMENT cannarx_i10q-093021_htm.xml XML 572984
Mailing Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5
Business Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5 949-652-6838
CANNAPHARMARX, INC. (Filer) CIK: 0001081938 (see all company filings)

EIN.: 274635140 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-27055 | Film No.: 211408048
SIC: 2834 Pharmaceutical Preparations